Option Care Health Acquires Houston-based BioCureRx for $18.5M
May 6, 2021
Option Care Health paid $18.5 million to acquire Houston-based BioCureRx, a regional provider of chronic care therapies. The purchase expands Option Care's regional footprint in home and alternate-site infusion services as the company increases M&A activity.
- Buyers
- Option Care Health
- Targets
- BioCureRx
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
BioMatrix Infusion Pharmacy Acquires Total Infusion Care
November 7, 2025
Healthcare Services
BioMatrix Infusion Pharmacy acquired Total Infusion Care (TIC), a Nevada-based provider of home and ambulatory infusion therapy serving patients across the western United States. The transaction closed on November 7, 2025, and TIC’s Henderson, Nevada location will continue operating as part of the BioMatrix network.
-
Better Choice Company to Acquire SRx Health Solutions for Approximately $125 Million
September 3, 2024
Healthcare Services
Better Choice Company Inc. (NYSE American: BTTR) signed a definitive all-stock agreement to acquire SRx Health Solutions Inc. for approximately $125 million. The deal would combine Better Choice's pet health business (Halo) with SRx's Canadian specialty pharmacy network, creating a broader health and wellness company and unlocking operational synergies and geographic/vertical expansion.
-
OptimizeRx Acquires Medicx Health for $95 million
October 12, 2023
Marketing & Advertising
OptimizeRx Corp. (Nasdaq: OPRX) has signed an agreement to acquire Scottsdale-based Medicx Health (Healthy Offers, Inc.) for $95 million, with certain Medicx managers rolling about $10.5 million into OptimizeRx stock. The acquisition will expand OptimizeRx's omnichannel reach by adding Medicx's patient-focused Micro-Neighborhood Targeting platform and analytics, and is expected to be immediately accretive and to increase consolidated revenue run-rate toward $100 million.
-
One Equity Partners Completes Strategic Investment in InfuCare Rx
January 12, 2022
Healthcare Services
One Equity Partners (OEP) has completed a strategic investment in InfuCare Rx, a Fairfield, New Jersey–headquartered provider of specialty home infusion therapies and clinical therapy management. Financial terms were not disclosed; OEP said the capital will be used to accelerate growth, expand into new regions and scale InfuCare Rx's digital care management platform serving patients with complex chronic conditions.
-
The Vistria Group Acquires BioCare, Inc.
November 8, 2021
Healthcare Services
The Vistria Group has acquired BioCare, Inc., a Tempe-based specialty pharmaceutical distributor, specialty pharmacy and pharmaceutical logistics provider. The deal is Vistria’s first investment from its $2.68 billion Fund IV and aims to support BioCare’s growth — both organically and via acquisitions — to expand access to therapies for rare and orphan diseases.
-
BioMatrix Specialty Pharmacy Acquires InfuCare LTD (Tyler, TX)
July 6, 2021
Healthcare Services
BioMatrix Specialty Pharmacy, based in Plantation, Florida, has acquired InfuCare LTD, a home infusion specialty pharmacy in Tyler, Texas. The transaction adds a Texas brick-and-mortar location to BioMatrix's national footprint and expands its infusion capabilities, payer contracts, and access to covered lives for therapies such as IVIG, anti-infectives, and parenteral nutrition.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.